Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Clinical Outcomes With Passive MPKs vs. Powered Prosthetic Knees

NCT05267639 · View on ClinicalTrials.gov ↗

Study Summary

The goal of this proposed project is to gather community-based data from the K4-level Transfemoral Amputee (TFA) population to aid in evidence-based prescription of powered prosthetic knees (i.e., choosing the right device to maximize the benefit for each patient). The investigators envision that this Level 1 submission will transition into a larger follow-on Level 2 trial that will explore a larger spectrum of patient populations (K2-K4), as well as testing additional Power Knees currently in development that are expected to become commercialized in the near future. The investigators intend to use this Level 2 trial data to guide the implementation of effective prescriptions towards those that can benefit most from a given device and limit prescription to those who would not see benefit in order to ensure the most judicious use of Department of Defense (DoD) and Veteran's Affairs healthcare dollars. The findings will also be shared with the research community to help drive the design of future devices by identifying what features and functions are most beneficial to which patient populations when the devices are used outside of the laboratory. In summary, more community-based data on how powered prosthetic knees compare with MPKs is needed to allow for improved clinical decision making and clinical outcomes.

Interventions

  • DEVICE Power Knee

Study Locations (2)

Massachusetts

  • Liberating Technologies, Inc. — Holliston

Texas

  • Hanger Clinic — Austin

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2022-05-01
Est. Completion 2024-08-28
Phase NA

Sponsor

Liberating Technologies

5 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05267639

The ClinicalTrials.gov registry entry for NCT05267639 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Liberating Technologies, which has 5 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 6 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention — of which Power Knee is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05267639 reports 2 study locations spanning 2 distinct geographic areas — top geographies include Massachusetts, Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05267639 about?

NCT05267639 is a clinical study titled "Clinical Outcomes With Passive MPKs vs. Powered Prosthetic Knees". The goal of this proposed project is to gather community-based data from the K4-level Transfemoral Amputee (TFA) population to aid in evidence-based prescription of powered prosthetic knees (i.e., choosing the right device to maximize the benefit for each patient). The investigators envision that th...

What is the current status of trial NCT05267639?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-05-01. Estimated completion is 2024-08-28.

What conditions does trial NCT05267639 study?

This clinical trial studies the following conditions: Amputation, Prosthesis User, Lower Limb Amputation Above Knee (Injury), Amputation; Traumatic, Leg, Lower, Limb; Absence, Congenital, Lower. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05267639?

The interventions under investigation include: Power Knee (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05267639?

This trial is sponsored by Liberating Technologies, which has 5 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05267639 being conducted?

This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial